Keywords: new, use, sanofi/, organon, arixtra, sanofi-synthelabo, announced

New use for Sanofi/ Organon's Arixtra

Article | 30 June 2003

Print This

Sanofi-Synthelabo and Organon have announced that Arixtra (fondaparinux sodium) has been approved by the US Food and Drug Administration for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in